Company Profile

Friulchem S.p.A. specializes in the research, development, manufacture and marketing of original and generic pharmaceutical products. Net sales by category of products break down as follows:
- veterinary products (81%): active pharmaceutical ingredients, antibiotics, antiparasitic and insecticides, anti-inflammatory and cardiotonic ingredients;
- generic products (19%): food supplements, cosmetics, etc.


Source: Cofisem - Last Update: 2024-10-01

Key Executives
Chief Executive Officer Disma Giovanni Mazzola
Head of Investor Relations Disma Giovanni Mazzola


Source: Cofisem - Last Update: 2024-10-01

Key Figures
Millenium 2023 2022 2021 2020 2019
Net sales 26,657 34,261 18,494 16,667 15,642
Consumed purchases 18,420 24,137 12,377 12,716 8,291
Labour costs 4,508 3,967 1,822 1,914 1,696
Operating profit 593 512 391 -308 343
Income tax 95 -64 81 -167 13
Net income -371 7 10 -311 63
Net income (Group share) -227 34 10 -311 63
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards Local GAAP Local GAAP Local GAAP Local GAAP Local GAAP

Source: Cofisem - Last Update: 2024-10-01

Shareholder information
Evultis SA 38.8 %
Fiduciaria Bernasconi SA 6.3 %
Free float 31.1 %
Friulia S.p.A. 23.8 %


Source: Cofisem - Last Update: 2024-10-01

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Friulchem


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.